"We are entering the golden age of predictive and generative artificial intelligence in health care, and these capabilities are being paired with novel types of technology, like spectroscopy and genetic sequencing, to optimize disease detection and care," Cody Simmons, co-founder and CEO of DermaSensor, in a statement announcing the FDA clearance. A "Monitor" result suggests no further evaluation is immediately necessary. ![]() ![]() An "Investigate Further" result suggests a specialist should examine the lesion.Ħ. A proprietary algorithm analyzes spectral data and delivers an assessment in real-time.ĥ. ![]() The wireless device is pressed against the lesion to record it.Ĥ. A doctor identifies a potentially cancerous lesion on a patient.Ģ.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |